May 4, 2020 / 7:03 AM / 24 days ago

BRIEF-ExpreS2ion To Support COVID-19 Diagnostic Antibody Development Project

May 4 (Reuters) - ExpreS2ion Biotech Holding AB:

* EXPRES2ION ANNOUNCES SUPPORTING AN ADVANTAGEOUS COVID-19 DIAGNOSTIC ANTIBODY DEVELOPMENT PROJECT

* EXPRES(2)ION AND ITS JOINT VENTURE PARTNER ADAPTVAC ARE ENGAGED IN DEVELOPMENT OF A UNIQUE CAPSID VIRUS-LIKE PARTICLE (VLP) COVID-19 VACCINE Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below